Jacques Médioni

10.4k citations
125 papers · 3.3k indexed · h-index 29
Topics
Renal cell carcinoma treatment (28 papers)Cancer Treatment and Pharmacology (16 papers)Renal and related cancers (14 papers)
Partner nations
FranceUnited StatesSpain

In The Last Decade

Jacques Médioni

113 papers receiving 3.2k citations

Peers

Jacques Médioni
Comparison fields: 5 of 111
  • Pulmonary and Respiratory Medicine 1.4k
  • Oncology 1.2k
  • Molecular Biology 1.0k
  • Cancer Research 584
  • Immunology 507
Replace Luís Teixeira with:
Luís Teixeira France
Mehmet Asım Bilen United States
Jens Atzpodien Germany
Patricia Pautier France
Antonio Gil‐Moreno Spain
J.H.J.M. van Krieken Netherlands
Yoshiki Mikami Japan
Hiro‐omi Kanayama Japan
Petronella O. Witteveen Netherlands
Martine Antoine France
Jacques Médioni relative to Luís Teixeira France Luís Teixeira's profile →
Citations per field
00.5×
Luís Teixeira · 1×
Citations per year

Countries citing papers authored by Jacques Médioni

Since Specialization
Citations

This map shows the geographic impact of Jacques Médioni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Médioni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Médioni more than expected).

Fields of papers citing papers by Jacques Médioni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Médioni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Médioni. The network helps show where Jacques Médioni may publish in the future.

Co-authorship network of co-authors of Jacques Médioni

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques Médioni. A scholar is included among the top collaborators of Jacques Médioni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques Médioni. Jacques Médioni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 1
4 0
5 16
6 1
7 41
8 2
9 36
10 15
11 5
12 171
13 31
14 72
15
Cancer pulmonaire non à petites cellules : particularités chirurgicales en fonction de l'âge
0
16
[Prostate cancer: update].
1
17 13
18 77
19
[New trends in assessment in anticancer treatments by phase II clinical trials].
3
20
Bloc auriculo-ventriculaire et torsades de pointe après surdosage par le sotalol.
3

About Jacques Médioni

Jacques Médioni is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 125 papers that have together received 3.3k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (28 papers), Cancer Treatment and Pharmacology (16 papers) and Renal and related cancers (14 papers). The work is most often cited by research in Oncology (1.2k citations), Pulmonary and Respiratory Medicine (1.4k citations) and Cancer Research (584 citations). Jacques Médioni has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Stéphane Oudard, Laure Fournier, Eugéniu Banu, Bernard Escudier, Antoine M. Dujon, Marc Riquet, Françoise Le Pimpec‐Barthes, C.A. Cuénod, D Manac'h and R. Thiam. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026